PredxBio is a techbio company harnessing the power of spatial biology to unravel the hidden circuitries of the tumor microenvironment and leveraging the most advanced form of AI to get to the “Why?” of cancer. They are making a difference today in predicting patient response to immunotherapy with over 90% accuracy and providing the “reasons” behind varying responses to therapy among patients in their clinical trials.
